SCHEMBL5878397

SCHEMBL5878397

CC(=O)Nc1ccc(Sc2nc([N]c3cc(C)n[nH]3)c3ccc(O)cc3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 10/20 0.47
AURKA O14965 10/20 0.47
SRC P12931 5/20 0.47
GSK3B P49841 5/20 0.47
AURKC Q9UQB9 1/20 0.47
SULT1A1 P50225 1/20 0.35
GLA P06280 1/20 0.35
HIF1A Q16665 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 1/20 0.34
CA12 O43570 1/20 0.34
BRD4 O60885 1/20 0.34
NR1I2 O75469 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
MB P02144 1/20 0.34
CYP1A1 P04798 1/20 0.34
CA3 P07451 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2201915 0.81 AURKA (0.58) AURKBAURKASRCGSK3BAURKC
SCHEMBL12430605 0.76 AURKA (0.80) AURKBAURKASRCGSK3BAURKC
SCHEMBL2203051 0.72 AURKA (0.60) AURKBAURKASRCGSK3BAURKC
SCHEMBL2200331 0.72 AURKA (0.58) AURKBAURKASRCGSK3BAURKC
SCHEMBL2203771 0.71 AURKA (0.54) AURKBAURKASRCGSK3BAURKC
SCHEMBL2202873 0.70 AURKB (0.56) AURKBAURKASRCGSK3BAURKC
SCHEMBL2204454 0.70 AURKA (0.73) AURKBAURKASRCGSK3BAURKC
SCHEMBL2203099 0.69 AURKB (0.63) AURKBAURKASRCGSK3BAURKC
SCHEMBL2204076 0.67 AURKB (0.56) AURKBAURKASRCGSK3BAURKC
SCHEMBL12430587 0.67 AURKA (0.80) AURKBAURKASRCGSK3BAURKC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087603-B2 Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-08-08 US disclosed
US-20040132781-A1 Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132781-A1 Pyrazole compounds useful as protein kinase inhibitors AURKC, AURKA, GSK3B AURKB 6/4885AURKA 2/4885SRC 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.